|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
121,380,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
2,187 |
2,187 |
98,220 |
Total Buy Value |
$0 |
$38,963 |
$38,963 |
$2,585,297 |
Total People Bought |
0 |
1 |
1 |
2 |
Total Buy Transactions |
0 |
1 |
1 |
4 |
Total Shares Sold |
100 |
200 |
8,325 |
31,716 |
Total Sell Value |
$2,787 |
$4,692 |
$233,035 |
$1,293,892 |
Total People Sold |
1 |
1 |
2 |
3 |
Total Sell Transactions |
1 |
2 |
6 |
12 |
End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-08 |
4 |
AS |
$90.13 |
$2,257,641 |
D/D |
(25,049) |
2,883,483 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-08 |
4 |
OE |
$4.18 |
$3,135 |
D/D |
750 |
2,908,532 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-07 |
4 |
AS |
$81.82 |
$6,121,005 |
D/D |
(73,413) |
2,907,782 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-07 |
4 |
OE |
$4.18 |
$7,365 |
D/D |
1,762 |
2,981,195 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-06 |
4 |
AS |
$80.33 |
$8,123,659 |
D/D |
(100,000) |
2,979,433 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-06 |
4 |
OE |
$4.18 |
$10,032 |
D/D |
2,400 |
3,079,433 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-05 |
4 |
AS |
$75.51 |
$2,458,352 |
D/D |
(31,183) |
3,077,033 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-05 |
4 |
OE |
$4.18 |
$11,704 |
D/D |
2,800 |
3,108,216 |
|
- |
|
Clark Ian T |
Director |
|
2020-05-04 |
4 |
AS |
$72.17 |
$194,137 |
D/D |
(2,690) |
1,302 |
|
- |
|
Clark Ian T |
Director |
|
2020-05-04 |
4 |
OE |
$4.18 |
$11,244 |
D/D |
2,690 |
3,992 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-04 |
4 |
AS |
$72.55 |
$4,684,096 |
D/D |
(63,971) |
3,105,416 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-04 |
4 |
OE |
$4.18 |
$56,158 |
D/D |
13,435 |
3,169,387 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-29 |
4 |
AS |
$80.11 |
$302,800 |
D/D |
(3,780) |
111,171 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-29 |
4 |
OE |
$4.18 |
$15,800 |
D/D |
3,780 |
114,951 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-29 |
4 |
AS |
$80.25 |
$3,482,294 |
D/D |
(43,351) |
3,155,952 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-29 |
4 |
OE |
$4.18 |
$4,347 |
D/D |
1,040 |
3,199,303 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-28 |
4 |
AS |
$80.02 |
$97,628 |
D/D |
(1,220) |
111,171 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-28 |
4 |
OE |
$4.18 |
$5,100 |
D/D |
1,220 |
112,391 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-28 |
4 |
AS |
$80.23 |
$1,049,573 |
D/D |
(13,082) |
3,198,263 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-28 |
4 |
OE |
$4.18 |
$1,313 |
D/D |
314 |
3,211,345 |
|
- |
|
Clark Ian T |
Director |
|
2020-04-27 |
4 |
AS |
$77.50 |
$41,695 |
D/D |
(538) |
1,302 |
|
- |
|
Clark Ian T |
Director |
|
2020-04-27 |
4 |
OE |
$4.18 |
$2,249 |
D/D |
538 |
1,840 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-23 |
4 |
AS |
$77.32 |
$386,615 |
D/D |
(5,000) |
111,171 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-23 |
4 |
OE |
$4.18 |
$20,900 |
D/D |
5,000 |
116,171 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-20 |
4 |
AS |
$72.25 |
$745,235 |
I/I |
(10,270) |
3,139,971 |
|
- |
|
707 Records found
|
|
Page 19 of 29 |
|
|